Literature DB >> 8795691

The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.

M Tanaka1, Y Yamazaki, M Hattori, K Tsushita, M Utsumi, S Yoshida.   

Abstract

The hypothesis that minor bcr/abl fusion mRNA is produced in blast crisis of chronic myelogenous leukemia (CML) is examined. The RNA transcripts encoding the minor and major bcr/abl fused protein were detected by polymerase chain reaction (PCR) using RNA from peripheral blood or bone marrow cells of eight patients with blast crisis or accelerated phase of CML. The mRNA encoding for major bcr/abl was detected in all eight cases. In four patients, however, transcripts encoding for minor bcr/abl mRNA were detected, as well as major bcr/abl mRNA. The presence of minor bcr/abl mRNA was verified with the hybridization with a junction-specific probe and DNA sequencing analysis of PCR products. The appearance of minor bcr/abl fusion mRNA was associated with the lymphoblastic immunophenotype of the blast cells. In two of these four patients, samples of initial diagnosis of chronic phase of CML were available, which did not show minor bcr/abl transcript. We conclude that the appearance of minor bcr/abl mRNA transcript is associated with the terminal evolution of CML in lymphoblastic crisis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795691     DOI: 10.1016/0145-2126(96)00010-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.

Authors:  Noriaki Kawano; Shinya Okuda; Shuro Yoshida; Hiroko Kugimiya; Masaki Ito; Nagako Horikawa; Nobuaki Chosa; Tomoko Hisakata; Tomoko Fukudome; Ryoko Sakurai; Kiyoshi Yamashita; Akira Ueda; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2011-11-08       Impact factor: 2.490

2.  A case with coexistence of major and minor BCR/ABL fusion transcript at lymphoblastic crisis of chronic myelogenous leukemia in patients with major BCR/ABL positivity during chronic phase.

Authors:  Sang Hyuk Park; Hyun-Sook Chi; Young-Uk Cho; Seongsoo Jang; Chan-Jeoung Park; Ho-Joon Im
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

3.  T-cell blast crisis of chronic myelogenous leukemia presented with coexisting p210 and p190 BCR-ABL transcripts and t(10;11)(q11;p15).

Authors:  Ting Xia; Yuchao Yang; Guoxia Li; Jianmei Chang; Jianlan Li; Fanggang Ren; Weixiao Ren; Hongwei Wang; Zhifang Xu
Journal:  J Clin Lab Anal       Date:  2020-02-13       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.